Yucai Wang

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke et al. · Journal of Clinical Oncology · 2023 · 176 citations · Full text

Medicine, Hematology, Oncology +16

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

Yucai Wang, Marcella Tschautscher, Kari G. Rabe et al. · Haematologica · 2019 · 132 citations · Full text

Medicine, Hematology, Oncology +13

Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Damien C. Weber, Yucai Wang, Robert C. Miller et al. · Neuro-Oncology · 2014 · 127 citations · Full text

Medicine, Oncology, Surgery +17

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal et al. · Journal of Hematology & Oncology · 2023 · 117 citations · Full text

Medicine, Hematology, Oncology +17

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

Michael Wang, Wojciech Jurczak, Pier Luigi Zinzani et al. · Journal of Clinical Oncology · 2023 · 106 citations · Full text

Medicine, Hematology, Pharmacology +16